| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/17/1994 | WO1994005785A1 Multicistronic expression units and their use |
| 03/17/1994 | WO1994005782A1 In vivo production of transgenic organ by introducing the transgene via lumen |
| 03/17/1994 | WO1994005777A1 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 03/17/1994 | WO1994005702A1 Extraction of collagen |
| 03/17/1994 | WO1994005697A1 Growth hormone potentiating molecules |
| 03/17/1994 | WO1994005696A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
| 03/17/1994 | WO1994005695A1 Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
| 03/17/1994 | WO1994005694A1 Platelet aggregation inhibitors |
| 03/17/1994 | WO1994005693A1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005690A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | WO1994005689A1 Cloning and expression of pur protein |
| 03/17/1994 | WO1994005639A1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 03/17/1994 | WO1994005634A1 Benzo-fused lactams promote release of growth hormone |
| 03/17/1994 | WO1994005334A1 Vascular in vivo expression of macrophage colony stimulating factor |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005328A1 Inhibition of tumor metastasis via neutralization of tissue factor function |
| 03/17/1994 | WO1994005323A1 Method for induction of antigen-specific immune tolerance |
| 03/17/1994 | WO1994005322A1 A plasmin activity reducing agent for treating a superficial corneal ablation wound and related screening method |
| 03/17/1994 | WO1994005321A1 Serum hepatic leaking enzyme activity depressant and hepatopathy remedy composition |
| 03/17/1994 | WO1994005320A1 Wound remedy |
| 03/17/1994 | WO1994005319A1 Brain function ameliorant composition, learning capacity enhancer, mnemonic agent, dementia preventive, dementia curative, or functional food with brain function ameliorant effect |
| 03/17/1994 | WO1994005318A1 Method of treating cell damage or depletion |
| 03/17/1994 | WO1994005317A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | WO1994005316A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | WO1994005315A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | WO1994005314A1 Peptide inhibitors of leukocyte adhesion |
| 03/17/1994 | WO1994005313A1 Treatment of gynecological malignancies with biologically active peptides |
| 03/17/1994 | WO1994005312A1 Medical preparations containing n-methylated cyclic undecapeptides |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005309A1 Use of platelet factor 4 to inhibit osteoblast proliferation |
| 03/17/1994 | WO1994005305A1 Digitalis-like compounds |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1994005303A1 Peptide diagnostics and therapeutics for spondyloarthropathies |
| 03/17/1994 | WO1994005296A2 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 03/17/1994 | WO1994005270A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass |
| 03/17/1994 | WO1994005269A1 Peptide inhibitors of selectin binding |
| 03/17/1994 | WO1994005252A1 Stabilized chewable antimicrobial animal foodstuff |
| 03/17/1994 | WO1994005156A1 Combination of germicidal agents |
| 03/17/1994 | WO1994002507A3 Methods for detecting pre-clinical iddm |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | WO1993018055A3 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 03/17/1994 | CA2144333A1 Long wap promoter for mammary expression of human protein c |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143739A1 Growth hormone potentiating molecules |
| 03/17/1994 | CA2143653A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | CA2143644A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | CA2143611A1 Cloning and expression of pur protein |
| 03/17/1994 | CA2143417A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2143186A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | CA2143111A1 Stabilized chewable antimicrobial animal foodstuff |
| 03/17/1994 | CA2141935A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | CA2141425A1 Nitrogen substituted acridine and cytochrome p450 inhibitors and methods of use |
| 03/17/1994 | CA2140920A1 Combination of germicidal agents |
| 03/17/1994 | CA2122912A1 Novel peptides, and platelet aggregation-inhibiting agents, blood coagulation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis inhibiting agents, agents for protecting platelet preparations for blood transfusion and platelet preparation packs for transfusion using said novel peptides |
| 03/17/1994 | CA2122628A1 Method for induction of antigen-specific immune tolerance |
| 03/17/1994 | CA2120956A1 New amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 03/16/1994 | EP0587311A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use |
| 03/16/1994 | EP0587255A1 Insulinotropic hormone |
| 03/16/1994 | EP0587180A2 Aryl urea (Thiourea) and cyanoguanidine derivatives |
| 03/16/1994 | EP0587055A1 Use of manganese superoxide dismutase (Mn-SOD) in low dosage for the production of pharmaca for the treatment of diseases |
| 03/16/1994 | EP0586909A2 Use of C1-inhibitor for the preparation of a medicament for the prophylaxes and therapy of the capillary leak syndroms and circulatory shock |
| 03/16/1994 | EP0586812A2 Medicaments comprising glicentin as active ingredient |
| 03/16/1994 | EP0586790A1 Amyloid precursor-like protein and uses thereof |
| 03/16/1994 | EP0586667A1 Refolding and purification of insulin-like growth factor i |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586613A1 Bradykinin antagonists |
| 03/16/1994 | EP0586607A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 03/16/1994 | EP0586596A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters |
| 03/16/1994 | EP0586592A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals |
| 03/16/1994 | EP0586589A1 Treatment of anorexia and related states. |
| 03/16/1994 | EP0586573A1 Endotoxin binding and neutralizing protein and uses thereof |
| 03/16/1994 | EP0586562A1 Radiolabeled metal-binding protein for the treatment of arthritis |
| 03/16/1994 | EP0586549A1 Selecting ligand agonists and antagonists |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586532A1 Method of using substance p to treat allergy |
| 03/16/1994 | EP0586521A1 Calcium, trace mineral, vitamin d and drug therapy combinations |
| 03/16/1994 | EP0586505A1 Heteroconjugate antibodies for treatment of hiv infection |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/16/1994 | EP0586451A1 Inhibition of smooth muscle cell proliferation by vitronectin |
| 03/16/1994 | EP0586381A1 Improved blood substitute |
| 03/16/1994 | EP0455789B1 Method of preventing or limiting reperfusion damage |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/16/1994 | EP0256127B1 Process for granulating enzyme |
| 03/16/1994 | CN1083822A Polyoxymethylene-oxyethylene copolymers in conjuction with biomolecules |
| 03/16/1994 | CN1083704A Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| 03/15/1994 | US5294720 1,4-diamino-2,3-dihydroxybutanes |
| 03/15/1994 | US5294713 Inhibiting cell adhesion |
| 03/15/1994 | US5294700 Oligosaccharides from syncytiotrophoblast microvilli membranes |
| 03/15/1994 | US5294699 Absorbers |
| 03/15/1994 | US5294698 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 03/15/1994 | US5294632 Diuretics and vasorelaxants |
| 03/15/1994 | US5294609 DNA gyrase inhibitors and pharmaceutical preparations therefor |
| 03/15/1994 | US5294605 Antimicrobial, antitumor |
| 03/15/1994 | US5294604 Side effect reduction |
| 03/15/1994 | US5294569 Endothelin DNA and use thereof |